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Abstract
Background: A unique feature of the pathological change after spinal cord injury (SCI) is the progressive
enlargement of lesion area, which usually results in cavity formation and is accompanied by reactive astrogliosis
and chronic inflammation. Reactive astrocytes line the spinal cavity, walling off the lesion core from the normal
spinal tissue, and are thought to play multiple important roles in SCI. The contribution of cell death, particularly the
apoptosis of neurons and oligodendrocytes during the process of cavitation has been extensively studied. However,
how reactive astrocytes are eliminated following SCI remains largely unclear.
Results: By immunohistochemistry, in vivo propidium iodide (PI)-labeling and electron microscopic examination,
here we reported that in mice, reactive astrocytes died by receptor-interacting protein 3 and mixed lineage kinase
domain-like protein (RIP3/MLKL) mediated necroptosis, rather than apoptosis or autophagy. Inhibiting receptor-
interacting protein 1 (RIP1) or depleting RIP3 not only significantly attenuated astrocyte death but also rescued the
neurotrophic function of astrocytes. The astrocytic expression of necroptotic markers followed the polarization of
M1 microglia/macrophages after SCI. Depleting M1 microglia/macrophages or transplantation of M1 macrophages
could significantly reduce or increase the necroptosis of astrocytes. Further, the inflammatory responsive genes
Toll-like receptor 4 (TLR4) and myeloid differentiation primary response gene 88 (MyD88) are induced in necroptotic
astrocytes. In vitro antagonizing MyD88 in astrocytes could significantly alleviate the M1 microglia/macrophages-
induced cell death. Finally, our data showed that in human, necroptotic markers and TLR4/MyD88 were co-
expressed in astrocytes of injured, but not normal spinal cord.
Conclusion: Taken together, these results reveal that after SCI, reactive astrocytes undergo M1 microglia/
macrophages-induced necroptosis, partially through TLR/MyD88 signaling, and suggest that inhibiting astrocytic
necroptosis may be beneficial for preventing secondary SCI.
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Background
One unique pathological change after primarily spinal
cord injury (SCI) is the secondary injury, which is charac-
terized by continuous tissue loss, reactive astrogliosis and
chronic inflammation, and usually leads to gradual expan-
sion of the lesion center and formation of a spinal cavity
[1, 2]. Elucidating the mechanisms of tissue loss, particu-
larly nerve cell death is important for preventing the ex-
pansion of the lesion area. Previous studies have paid
attention to the glutamate-induced apoptosis of neurons
and oligodendrocytes within and around the lesion center
[3–5]. However, how reactive astrocytes, which are the
major component of the glial scar, play diverse roles in
SCI [6] and are particularly important in supporting neur-
onal survival [6], are eliminated remains poorly investi-
gated. Understanding the mechanism of astrocytic death
post-SCI may yield new insights into understanding the
* Correspondence: jugong@fmmu.edu.cn; yazhouw@fmmu.edu.cn
†Equal contributors
1Department of Neurobiology and Collaborative Innovation Center for Brain
Science, School of Basic Medicine, Fourth Military Medical University, Xi’an
710032, China
Full list of author information is available at the end of the article
© 2016 Fan et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fan et al. Molecular Neurodegeneration  (2016) 11:14 
DOI 10.1186/s13024-016-0081-8
mechanism of secondary SCI and improving functional
recovery.
Chronic inflammation plays an essential role in stimu-
lating astrocyte activation and progressive cavitation [7, 8].
After SCI, inflammation is mainly generated by activated
microglia/macrophages, which are constituted by their
two phenotypically distinct subpopulations, the pro-
inflammatory M1, and the anti-inflammatory M2 micro-
glia/macrophages [9]. Compared to the immune reaction
in peripheral tissue injury, the polarization of microglia/
macrophages post-SCI is M1 predominant and lasts lon-
ger [10–12]. Previous study has revealed the apoptosis-
inducing effects of M1 microglia/macrophages on neurons
and oligodendrocytes [11]. Whether and how the activity
of M1 microglia/macrophages affects the survival of react-
ive astrocytes remains unclear.
In the present study, we analyzed the death of reactive
astrocytes in mice and human after spinal contusion, and
reported that reactive astrocytes die through necroptosis,
a type of programmed necrosis for which the molecular
mechanisms have been recently unraveled [13], and is in-
duced by M1 microglia/macrophages, partially via TLR/
MyD88 signaling. Our data indicated that blocking the
necroptosis of reactive astrocytes might reduce secondary
injury and promote functional recovery after SCI.
Results
Cavity-surrounding reactive astrocytes undergo necrosis
rather than apoptosis or autophagy during the progress
of secondary SCI
A modified spinal contusion model which was more ex-
perimentally consistent was adopted [14, 15]. Spinal cav-
ity enlarged gradually and reached plateau by 2 weeks
post-injury, with reactive astrocytes surrounded at all
time points assessed (Fig. 1a). We first tested whether
apoptosis or autophagy accounted for the loss of reactive
astrocytes during the development of secondary injury.
Because immunohistochemistry of GFAP stains primar-
ily processes and seldom cell bodies, we adopted GFAP-
CreER:ROSA-YFP mice to visualize the cell bodies of
astrocytes. Tamoxifen (2.5 mg) was injected for 5 succes-
sive days before SCI to label astrocytes by YFP (Fig. 1b).
Double-immunostaining of YFP with TUNEL at 5 days
post injury (dpi) showed that very rare could YFP/
TUNEL-double positive cells be found, precluding the
apoptosis of astrocytes. Double-immunostaining of YFP
with autophagic markers showed that in bilateral areas
from 400 μm rostral and caudal to border of lesion cen-
ter defined by YFP/GFAP-immunoreactivity (Fig. 1d),
approximately 9.8 % of YFP-positive cells were Lamp2a-
positive, 6.3 % were LC3-positive and 8.1 % were
Beclin1-positive (Fig. 1c). These data suggest that in
mice, during the process of cavitation, reactive astrocytes
may be eliminated by ways other than apoptosis and
autophagy.
To test whether reactive astrocytes could undergo ne-
crosis, the third major type of cell death, we performed
live-animal propidium iodide (PI)-labeling. Besides within
lesion center, PI-labeled cells could be found in areas
around the epicenter. PI- and GFAP-positive cells in bilat-
eral areas from 400 μm rostral and caudal to border of le-
sion center defined by GFAP-immunoreactivity were
quantified (Fig. 1d). From 3 to 14 dpi, about 80 % of all
PI-labeled cells in these regions were GFAP-positive
(Fig. 1e). The percent of astrocytes with PI-labeling
reached peak at 5 dpi (Fig. 1e). These data indicate that re-
active astrocytes around the spinal cavity undergo necrosis
during the process of secondary injury.
Necroptosis of reactive astrocytes after SCI
Necroptosis is a type of programmed necrosis for which
the molecular mechanisms have recently been uncovered
[16]. Death signals activate an intracellular signaling which
is mediated mainly by protein complexes involving
receptor-interacting protein 1 (RIP1), receptor-interacting
protein 1 (RIP3) and mixed lineage kinase domain-like
protein (MLKL), leading to disruption of cell membranes
and lysis of cytoplasmic contents [16, 17]. To test whether
necroptosis occurs in the reactive astrocytes after SCI, we
first examined the expression of RIP3 in mice by
Western-blotting. The expression of RIP3 increased sig-
nificantly from 3 dpi to 7 dpi (Fig. 2a). Immunohistochem-
istry detected strong RIP3-immunoreactivity around
lesion center, with most expressed by GFAP-positive cells
(Fig. 2b). Quantification showed that at all time points ex-
amined, approximately 80 % of the RIP3-positive cells
were GFAP-positive (Fig. 2b), which was consist with the
results of PI-labeling (showed by Fig. 1e). OX42-positive,
NeuN-positive, and CC-1-positive cells constituted for the
remainder of RIP3-positive cells (Fig. 2c). MLKL, another
key molecule in execution of necroptosis [18], was also in-
duced by SCI and expressed in reactive astrocytes (Fig. 2d).
In addition, HMGB1, a member of high mobility group
box protein that normally binds to chromatin and is re-
leased by necrotic cells [19], was detected in the cytoplasm
of GFAP-positive cells (Fig. 2e), supporting the occurrence
of necrosis in astrocytes.
To confirm the necroptosis of astrocytes after SCI, we
performed immune-electron microscopic study in spinal
tissue within 5 mm around lesion center at 5 dpi in mice.
Astrocytes with focal lysis of cytoplasm and RIP3 immu-
noreactivity on the cytoplasmic fibrils were frequently
found (Fig. 2f). MLKL-immunoreactivity was found both
at the cell membrane and within the bundles of cytoplas-
mic fibrils (Fig. 2g), consistent with its role in penetrating
the cell membrane during necroptosis [20]. No apoptotic-
like astrocytes were observed. Taken together, these data
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suggested that reactive astrocytes may undergo RIP3/
MLKL-mediated necroptosis after SCI in mice.
In vitro inflammatory stimulation of necroptosis in
astrocytes
We then examined whether necroptosis could be mod-
eled in reactive astrocytes in vitro. Mouse spinal cord as-
trocytes were cultured and purified as described [21, 22].
Only batches of cells in which the percent of GFAP-
positive cells was over 99 % were used for cell death in-
duction (Additional file 1: Figure S1). The cells were
challenged with tumor necrosis factor alpha (TNFα) and
lipopolysaccharide (LPS) to mimic the inflammatory
microenvironment in vivo, and z-VAD, a pan-caspase in-
hibitor was added to inhibit apoptosis as routinely used
by researchers when inducing necroptosis [17, 18].
Forty-eight hours treatment of TNFα, LPS and z-VAD
(TLZ) significantly increased the expression of RIP3,
MLKL, and cytoplasmic HMGB1, while decreased nu-
cleus levels of HMGB1 (Fig. 3a–d). Upon TLZ treat-
ment, the intracellular level of reactive oxygen species
(ROS) and the percent of PI-labeled astrocytes were sig-
nificantly increased, and intracellular level of ATP signifi-
cantly decreased (Fig. 3e–i). These data indicate that
necroptosis of astrocytes can be induced by TLZ in vitro.
Further, Necrostatin-1 (Nec-1), a well-used necroptosis
inhibitor that inhibits phosphorylation of RIP1 [23], sig-
nificantly compromised the increase of RIP3, MLKL,
cytoplasmic high mobility group box 1 (HMGB1), intra-
cellular ROS, extracellular ATP and PI-labeling induced
by TLZ treatment (Fig. 3a–i), indicating a rescuing ef-
fect of Nec-1 on astrocyte death. Because Nec-1 also in-
hibits indoleamine-2,3-dioxygenase (IDO) [24], we then
used RIP3−/− astrocytes to confirm the occurrence of
Fig. 1 Non-apoptotic or autophagic death of reactive astrocytes after SCI in mice. a Immunohistochemistry of GFAP and the size of spinal cavity
at different time points after SCI. The spinal cavity enlarges gradually with reactive astrocytes at its border, and reaches plateau at 14 days post-injury in our
model. Bar = 200 μm (b, c) Strategy for astrocytes labeling and Double-staining of YFP with apoptotic marker (TUNEL) and autophagic markers (Lamp2a,
LC3 and Beclin-1) at 5 dpi. GFAP-CreER : ROSA-YFP mice were used, and Tamoxifen was injected for 5 successive days before SCI to label astrocytes by
YFP. Notice that No double-staining of YFP/TUNEL was found. Only few YFP-positive cells express autophagic markers. Bar = 25 μm. d Schematic drawing
of morphological quantification area. For quantification of immunostainings, immunoreactivities within two adjacent areas which were 400 μm rostral or
caudal to the cavity border in each spinal section were analyzed. e 3-D reconstruction of combined PI-labeling and immunohistochemistry of GFAP, and
quantification of GFAP- and PI-positive cells. Arrows in C and E point to double positive cells. Bar = 5 μm. **P <0.01. n= 3
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astrocytic necroptosis. The effects of TLZ on ROS
production, ATP level and PI-permeability in wild-type
astrocytes were significantly abolished in RIP3−/− astro-
cytes (Fig. 3e–i). These data demonstrated the necrop-
tosis of mouse astrocytes in vitro.
Inhibiting necroptosis rescues both the death and
neurotrophic phenotype of reactive astrocytes after SCI
We next examined the effects of inhibiting necropto-
sis on the survival of astrocytes after SCI. Five
successive days of treatment by Nec-1 significantly
decreased the percent of PI-positive astrocytes and
the expression of RIP3, MLKL and HMGB1 in areas
surrounding lesion center (defined as Fig. 1c), as
compared to PBS control (Fig. 4a, b). RIP3−/− mice
showed a significant decrease of PI-labeled astrocytes
at 5 dpi, as compared to wild type mice (Fig. 4c).
The expression of MLKL and HMGB1 was also sig-
nificantly lower in injured RIP3−/− spinal cord as
compared to wild-type control (Fig. 4d). These data
Fig. 2 Necroptosis of reactive astrocytes in injured mice spinal cord. a Western-blotting of RIP3 after SCI. Notice that the increase of RIP3 from 3
to 7 days post-injury. *P <0.05, **P <0.01. n = 3. b Double staining and quantification of RIP3 and GFAP at 5 days post-injury. Notice that at all time
points, most RIP3-positive cells were GFAP-positive. Arrows points to RIP3/GFAP double-positive cells. Bar = 100 μm. Bar in insert = 50 μm.
c Double-staining and quantification of RIP3 with OX42, NeuN and CC1. Notice that micoglia, neurons and oligodendrocytes account for a small
portion of RIP3-positive cells. Bars = 50 μm. d, e Double staining of GFAP with MLKL and HMGB1. Many astrocytes around lesion center express
MLKL and cytoplasmic HMGB1, shown by arrows. Bars = 100 μm. Bars in inset = 50 μm. f Immuno-eletron microscopic study of RIP3. Notice the
focal cytoplasmic lysis of astrocyte (asterisks) and localization of RIP3 immunoreactivity on glial fibrils (arrows). Bar = 1 μm. g Immuno-eletron
microscopic study of MLKL. Notice the fibrils (arrows in G1) and membrane localization (arrows in G2) of MLKL. Focal cytoplasmic lysis was shown
by asterisks. Bar = 2 μm
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indicate that inhibiting necroptosis after SCI could ef-
fectively prevent the death of astrocytes.
Because astrocytes are well known for their supportive
roles in neuronal survival and neurons around the lesion
center die after SCI, we then tested whether necroptosis
could affect neurotrophic function of reactive astrocytes.
Conditioned medium (CM) of normal astrocytes, TLZ
treated necroptotic astrocytes, and necroptosis inhibited
astrocytes which was treated by TLZ plus Nec-1 (TLZN)
were used to treat primary cultured neurons. Twenty-
four hours later, more TUNEL-positive neurons were
observed in cells treated by CM of necroptotic astrocytes
in comparison with those in cells treated by CM of nor-
mal astrocytes (Fig. 5a). A significantly less TUNEL-
positive neurons were observed in cells treated by CM
of TLZN treated astrocytes, as compared to that of TLZ
treated astrocytes (Fig. 5a). Further, we examined the ef-
fects of necroptosis inhibition on the expression of glial
cell line-derived neurotrophic factor (GDNF) by reactive
astrocytes after SCI. Both Nec-1 and RIP3 depletion sig-
nificantly enhanced the expression of GDNF by reactive
astrocytes (Fig. 5b, c). We then measured the number of
Fig. 3 Necroptosis of mouse spinal cord astrocytes in vitro. a, b Western-blotting of RIP3 and MLKL in control, TLZ (TNFα, LPS and Z-VAD), TLZN (TLZ plus
Nec-1). Notice that TLZ significantly increased the expression of RIP3 and MLKL. This effect was significantly suppressed by Nec-1. **P <0.01, *P <0.05. n= 3.
c, dWestern-blotting of cytoplasmic and nuclear HMGB1 in control, TLZ or TLZN-treated astrocytes. Notice that TLZ significantly increased cytoplasmic
HMGB1, but decreased nuclear HMGB1. The effects of TLZ on HMGB1 were blocked by Nec-1. e ROS staining in control, TLZ treated, TLZN treated and
RIP3−/− astrocytes. f PI-staining in control, TLZ treated, TLZN treated and RIP3−/− astrocytes. g, h Quantification of intracellular ROS and ATP levels in
astrocytes under various conditions. i Percentages of PI-positive cells in TLZ treated, TLZN treated astrocytes and TLZN treated RIP3−/− astrocytes. Bars in (e),
F = 50 μm. **P <0.01. *P <0.05. n= 3
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neurons in areas 400 μm rostral and caudal to the spinal
cavity at 14 dpi after 7 days treatment by Nec-1 or in
RIP3−/− mice, which were thought to undergo apoptosis
during secondary injury. The results showed a significant
increase of NeuN-positive cells as well as a smaller size of
spinal cavity in Nec-1 treated and RIP3−/− mice (Fig. 5d, e).
Taken together, these data suggest that inhibiting necropto-
sis after SCI not only attenuates astrocyte death but also
rescues the neurotrophic function of reactive astrocytes,
thereby promoting adjacent neuronal survival.
Induction of necroptosis of reactive astrocytes by M1
microglia/macrophages
As inflammatory factors can induce astrocytic necropto-
sis in vitro and M1 microglia/macrophages has been
thought to be the major source of toxic inflammatory
factors after SCI [12], we hypothesized that M1 micro-
glia/macrophages might induce astrocytic necroptosis
after SCI. Western-blotting showed that the expression
of inducible nitric oxide synthase (iNOS), a commonly
used marker for M1 microglia/macrophages, increased
quickly from 1 day and peaked at 3 day post-SCI. The
expression of MLKL and HMGB1 increased gradually
and peaked at 5 dpi, just following the increase of iNOS
(Fig. 6a). To directly investigate the effects of M1
microglia/macrophages on astrocytes, we polarized pri-
marily cultured microglia/macrophages toward either
M1 or M2 phenotype, and stimulated astrocytes with
conditioned medium collected from M0 (normal cul-
tured microglia/macrophages), M1, and M2 microglia/
macrophages. The polarization of microglia or macro-
phages was confirmed by the expression of iNOS and argi-
nase 1, a typical marker for M2 microglia/macrophages
(Additional file 2: Figure S2). All three CMs increased the
expression of RIP3, MLKL and HMGB1 in cultured astro-
cytes. Of note, CM of M1 microglia/macrophages (M1
CM) showed the strongest induction of these necroptosis
markers (Fig. 6b, Additional file 3: Figure S3). In addition,
intracellular ATP was significantly decreased, and the
number of PI-labeled cells increased in astrocytes treated
by M1 CM (Fig. 6c, d).
To investigate the death-inducing effects of M1 micro-
glia/macrophages on astrocytes in vivo, we depleted M1
microglia by administration of gadolinium chloride
(GdCl3) in the lesion site as described [25], which in-
duces apoptosis of inflammatory macrophages via com-
petitive inhibition of Ca2+ mobilization and damage to
plasma membranes [26, 27]. Depletion of M1 microglia/
macrophages was confirmed by reduced expression of
iNOS (Additional file 4: Figure S4). In comparison with
PBS control, GdCl3 treatment significantly reduced the ex-
pression of RIP3, MLKL and HMGB1, and decreased the
percent of PI-labeled astrocytes within bilateral regions
400 μm rostral and caudal to the epicenter (Fig. 7a, b).
Consistently, smaller spinal cavity at 14 dpi and better
locomotion recovery from 6 dpi were observed in GdCl3
treated mice (Fig. 7c, d).
To further confirm the effects of M1 microglia/macro-
phages on astrocyte death and spinal cavity, we prepared
primary cultured macrophages from bone marrow, and
transplanted M0 and M1-polarized macrophages into
the injured spinal cord. Transplantation of M1 macro-
phages resulted in a dramatic increase of RIP3, MLKL
and HMGB1 expression and the number of PI-labeled
astrocytes, while transplantation of M0 macrophages
only showed minor effects, as compared to Dulbecco’s
Fig. 4 Effects of necroptosis inhibition on astrocyte death after SCI in mice. a Combination of PI-labeling with immunohtistochemistry of GFAP
in mice treated with PBS or Nec-1 at 5 days post-injury. Nec-1 significantly reduced the percent of PI-positive astrocytes. Bar = 50 μm. *P <0.05.
n = 3. b Western-blotting of RIP3, MLKL and HMGB1 in spinal cord of PBS treated or Nec-1 treated mice at 5 days post-injury. Nec-1 significantly
inhibited the expression of RIP3, MLKL and HMGB1, as compared to PBS control. *P <0.05. n= 3. c Combination of PI-labeling with immunohtistochemistry
of GFAP in wild-type (WT) and RIP3−/− mice. RIP3 depletion significantly reduced the percent of PI-positive astrocytes. Bar = 50 μm. *P <0.05.
n = 3. d Western-blotting of RIP3, MLKL and HMGB1 in spinal cord of WT and RIP3−/− mice. RIP3 mutation significantly reduced the SCI-induced
expression of RIP3, MLKL and HMGB1. ***P <0.001, *P <0.05. n = 3
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Modified Eagle’s Medium (DMEM) control (Fig. 7e, f ).
Likewise, the spinal cavity was significantly larger at 14
dpi, and the locomotion recovery worse from 5 dpi in
M1 macrophage-transplanted mice (Fig. 7g, h). Taken
together, these data indicate that M1 micoglia/macro-
phages play an inductive role in the necroptosis of astro-
cytes after SCI.
Involvement of astrocytic TLR/MyD88 signaling in M1
microglia/macrophage-induced necroptosis
As showed above, LPS was required for the in vitro induc-
tion of astrocytic necroptosis. We thus speculated that
toll-like receptors (TLR) and their downstream molecules
might be involved in the M1 microglia/macrophages-in-
duced astrocytic necroptosis. Among TLRs members,
TLR2 and TLR4 respond to same type of stimulus and
have been thought to be involved in astrocyte activation
[28, 29]. Double-staining of GFAP with TLR2 or TLR4
showed that only a minor portion of reactive astrocytes
surrounding spinal cavity express TLR2, while most react-
ive astrocytes express TLR4 (Fig. 8a, b). We then focused
on the expression of TLR4 and the intracellular adaptor
molecule MyD88. The immunoreactivity of TLR4 over-
lapped very well with that of RIP3 in the injured mouse
spinal cord (Fig. 8c). MyD88 was also highly expressed in
reactive astrocytes (Fig. 8d), suggesting that TLR4/MyD88
signaling was activated in necroptotic astrocytes after SCI.
In vitro, TLZ treatment stimulated a dramatic increase of
TLR4 and MyD88, as well as a moderate increase of
TLR2, in astrocytes (Fig. 8e, Additional file 5: Figure S5).
A TAT-tagged MyD88 inhibitory peptide which could
block the homodimerization of MyD88 was added into
culture medium of astrocytes to antagonize the function
of MyD88 [30]. The MyD88 inhibitory peptide signifi-
cantly suppressed the increase of RIP3 and PI-labeling in
astrocytes induced by TLZ treatment (Fig. 8f–h), suggest-
ing that TLR/MyD88 may be required for the activation of
necroptotic signaling in astrocytes.
Fig. 5 Effects of necroptosis on the neurotrophic function of astrocytes. a TUNEL staining of primary spinal cord neurons treated with CM from
normal, necroptotic, and necroptosis-inhibited astrocytes. Notice that necroptotic astrocytes were neurotoxic and their detrimental effects on
neurons could be alleviated by Nec-1. Bar = 50 μm. **P <0.01, *P <0.05. n = 3. b Double-staining of GFAP and GDNF in PBS and Nec-1 treated mice.
Nec-1 treatment significantly increased the number of reactive astrocytes which express GDNF. Bar = 50 μm. *P <0.05. n = 3. c Double-staining of
GFAP and GDNF in WT and RIP3−/− mice. RIP3 depletion significantly increased the number of reactive astrocytes which express GDNF. Bar = 50 μm.
*P <0.05. n = 3. d Cavity area and the number of neurons in adjacent regions which were 400 μm rostral and caudal to cavity border at 14 days post-
injury in mice treated with PBS or Nec-1. Nec-1 significantly improved neuronal survival and reduced cavity area. Bars = 150 μm. *P <0.05. n = 6. e Cavity
area and the number of neurons in adjacent regions which were 400 μm rostral and caudal to cavity border at 14 days post-injury in WT and RIP3−/−
mice. RIP3 mutation significantly improved neuronal survival and reduced cavity area. Bars = 150 μm. *P <0.05. n = 6
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We then examined the effects of M1 microglia/mac-
rophages on the expression of TLR4 and MyD88 in
astrocytes. Conditioned medium from M1 macrophages
significantly increased the expression TLR4 and MyD88
(Fig. 8i). The MyD88 inhibitory peptide effectively blocked
the induction of RIP3 by M1 macrophages (Fig. 8j). In
vivo, GdCl3 treatment significantly decreased the percent
of astrocytes expressing TLR4 or MyD88 by approxi-
mately 39 and 47.4 %, respectively (Fig. 8k, l). In contrast,
transplantation of M1 macrophages significantly increased
the number of astrocytes expressing TLR4 and MyD88,
compared to the DMEM control (Fig. 8k, l). These data
indicate that in mice, TLR/MyD88 signaling may be in-
volved in the M1 microglia/macrophage-induced necrop-
tosis of astrocytes.
Expression of necroptotic markers and TLR4/MyD88 in
astrocytes of injured human spinal cord
The above experiments in mice indicated that after SCI,
reactive astrocytes died by necroptosis, which was in-
duced by M1 microglia/macrophages, partially through
TLR/MyD88 mediated signaling. We next tested
whether similar pathological changes could occur in hu-
man after SCI. Immunohistochemistry showed a very
weak expression of RIP3 and MyD88, mainly by astro-
cytes in normal human spinal cord (Fig. 9a, e). No ex-
pression of MLKL, HMGB1 and TLR4 was detected in
normal human spinal cord (data not shown). However,
after SCI, strong RIP3-, phosphorylated-MLKL- (pMLKL)
and HMGB1-immunoreactivities were detected in GFAP-
positive cells around the lesion center in one patient
at 5 dpi (Fig. 9b–d). Interestingly, TLR4- and MyD88-
immunoreactivities were also detected in RIP3-positive or
GFAP-positive cells (Fig. 9f–h). Similar expression pat-
terns of RIP3, pMLKL, HMGB1, TLR4 and MyD88 were
observed in another patient at 15 dpi (data not shown).
These results suggested that in human, reactive astrocytes
may also undergo necroptosis after SCI.
Discussion
Necrosis has been traditionally thought to account for
the acute cell loss post-SCI and be uncontrollable [31].
Fig. 6 M1 microglia/macrophages induce necroptosis of spinal cord astrocytes in vitro. a Western-blotting and quantification of iNOS, MLKL and
HMGB1 after SCI. Notice the increase of iNOS is followed by the increase of MLKL and HMGB1. *P <0.05, **P <0.01. n = 3. b Western-blotting and
quantification of RIP3, MLKL and HMGB1 in astrocytes treated with conditioned medium (CM) from M0 microglia (M0 CM), M1 microglia (M1 CM),
and M2 microglia (M2 CM). Notice that M1 CM has the strongest effects in stimulating the expression of RIP3, MLKL and HMGB1. *P <0.05, **P <0.01.
n = 3. c, d Intracellular ATP levels and PI-staining in astrocytes treated by M0 CM, M1 CM, and M2 CM. Dramatic decrease of ATP levels and increase of
PI-staining were observed in M1 CM treated astrocytes. *P <0.05, **P <0.01. n = 3. n = 3. Bar = 50 μm
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Recent progress in the field of cell death has identified a
novel type of programmed necrosis, necroptosis [23], and
unveiled the underlying molecular mechanism, which is
mediated by an intracellular RIP1/3/MLKL signaling cas-
cade [32, 33], thereby offering an opportunity for re-
examining necrosis after SCI. Previous studies have re-
ported protective effects of Nec-1 on SCI in rats without
knowing the cell types that Nec-1 targets [34, 35]. Our
in vivo PI-labeling showed that astrocyte was the major
type of cells that undergo necrosis after SCI. The
Fig. 7 Effects of depleting M1 microglia/macrophages or transplantation of M1 macrophages on astrocytic death and functional recovery.
a Western-blotting ofRIP3, MLKL and HMGB1 at 5 days post-injury in GdCl3- or PBS- treated mice. GdCl3 treatment significantly blocked the
induction of RIP3, MLKL and HMGB1 by SCI. *P <0.05. n = 3. b Double-staining of GFAP and PI at 5 days post-injury in GdCl3 or PBS treated mice.
GdCl3 treatment significantly reduced the percent of PI-labeled astrocytes. Bar = 50 μm. *P <0.05. n = 3. c, d Quantification of cavity area at 14 days
post-injury and evaluation of locomotion recovery in GdCl3 and PBS treated mice. GdCl3 treatment significantly reduced cavity size and enhanced
functional recovery. BMS stands for for Basso mouse scale. Bars = 200 μm. *P <0.05. n = 3. e, f Western-blotting of RIP3, MLKL and HMGB1, and
double-staining of GFAP and PI in injured spinal cord at 5 days after transplantation of M0 macrophages or M1 macrophages. M1 macrophages
significantly increased the expression of RIP3, MLKL and HMGB1, and the number of PI-labeled astrocytes, as compared to DMEM control. Bar = 50 μm.
**P <0.01, *P <0.05. n = 3. g, h Quantification of cavity area and locomotion recovery after transplantation of DMEM, M0 macrophages or M1
macrophages. Transplantation of M1 macrophages significantly expanded the area of spinal cavity and impeded function recovery. BMS stands
for for Basso mouse scale. *P <0.05. n = 3. Bars = 200 μm
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Fig. 8 Involvement of TLR4/MyD88 signaling in M1 microglia/macrophages-induced necroptosis of astrocytes. a, b Double-staining of GFAP with TLR2 or
TLR4. Notice that many GFAP-positive cells around the lesion center express TLR4 (arrows). Bars = 50 μm. c, d Double-staining of RIP3/TLR4 and MyD88/
GFAP. Notice that there are many RIP3/TLR4 and MyD88/GFAP double-positive cells (showed by arrows) in the injured mouse spinal cord. Bars = 50 μm.
eWestern-blotting of TLR4 and MyD88 in cultured astrocytes after treatment with TLZ or vehicle control. TLZ treatment dramatically induced the
expression of TLR4 and MyD88. f–h Western-blotting of RIP3 and PI-staining in astrocytes treated with vehicle control, TLZ, TLZ plus control peptide
(MyD88 con pep), and TLZ plus a MyD88 inhibitory peptide (MyD88 inh pep). Notice that MyD88 inhibitory peptide significantly suppressed the effects of
TLZ on the expression of RIP3 and MLKL and PI-labeling. **P <0.01, *P <0.05. n= 3. Bar = 50 μm. i Western-blotting of TLR4, MyD88 in normally cultured
astrocytes, and astrocytes treated with M0 CM, M1 CM, and M2 CM from microglia/macrophages. Notice that M1 CM significantly increased the expression
of TLR4 and MyD88. **P <0.01, *P <0.05. n = 3. j Western-blotting of RIP3 in astrocytes treated with DMEM control, M0 CM, M1 CM, and M2 CM.
k, l Double-staining of GFAP with TLR4 and MyD88 at 5 dpi in DMEM injected, GdCl3 treated or M1 macrophages transplanted mice. Notice that
GdCl3 treatment significantly decreased, while transplantation of M1 macrophages significantly increased the percent of astrocytes expressing
TLR4 or MyD88 in adjacent regions which were 400 μm rostral and caudal to cavity border. *P <0.05. Bars = 50 μm. n = 3
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ultrastructural localization of RIP3 and MLKL on the
cytoplasmic glial fibrils confirmed the astrocytic
necroptosis in SCI. Interestingly, PI-positive astrocytes
persisted for 2 weeks in injured spinal cord, indicating
that chronic necrosis may be an important contributor
of cavity formation post-SCI. We recently reported that
microglia/macrophages undergo necroptosis after SCI
[36], which was consistent with our observation that
RIP3 was primarily expressed by reactive astrocytes,
and secondarily expressed by microglia/macrophages
(Fig. 2b, c). Considering the fact that inflammation
plays critical roles in the cavity formation after SCI, the
beneficial effects of necroptosis inhibition on SCI may
be results from the protection of astrocytes, microglia/
macrophages, as well as other cells.
The innate immune reaction produced by microglia/
macrophages has been demonstrated to contribute to
the cavity formation and enlargement after SCI [7]. The
destructive effects of activated microglia/macrophages
were largely attributed to their M1 sub-group, which
was activated quickly after SCI and expressed high levels
of pro-inflammatory cytokines, including the well-
studied necroptosis inducing factor TNFα [23, 37]. It is
therefore reasonable to speculate a link between M1
micorglia/macrophages and astrocyte death after SCI,
which has been poorly investigated. Our data showed
that in vitro, conditioned medium of M1 microglia/
macrophages could induce necroptosis of astrocytes. In
vivo, depletion of M1 microglia/macrophages by GdCl3 or
transplantation of M1 macrophages can reduce or en-
hance necroptosis of astrocytes respectively. These results
indicated a critical role of M1 microglia/macrophages in
inducing the necroptosis of astrocytes after SCI. Consider-
ing that GdCl3 also affects neutrophils [38], which are
abundant in the injury epicenter after SCI, and that iNOS
can also be expressed by neutrophils [39]. The beneficial
effects of GdCl3 treatment may also be contributed by the
inhibition of neutrophils.
Although the identities of death factors released by
M1 microglia/macrophages remain unclear, our data
showed that TLR4 and MyD88 were up-regulated in
necroptotic astrocytes after SCI and M1 CM could in-
crease the expression of TLR2, TLR4 and MyD88 in as-
trocytes. Previous researches have reported that TLR4 is
involved in the necroptosis of macrophages in vitro and in
the activation of astrocytes after SCI [40, 41]. These results
indicated that M1 microglia/macrophages may induce the
necroptosis of astrocytes by activating TLR4/MyD88 signal-
ing. In consistent, inhibiting MyD88 could partially block
the necroptosis-inducing effect of M1 microglia/macro-
phages in vitro. In addition, the expression of TLR4/
MyD88 in human necroptotic astrocytes indicated a com-
mon response of this signaling pathway after SCI. Consider-
ing that MyD88 mediates the downstream signals of
Fig. 9 Expression of necroptotic markers and TLR/MyD88 by astrocytes in injured human spinal cord. a Double-staining of GFAP with RIP3 in
uninjured human spinal cord. Notice the very weak expression of RIP3. Bar = 50 μm. b–d Representative images of double-staining of GFAP with RIP3,
pMLKL and HMGB1 in human spinal cord at 5 days post-injury. Notice the co-localization of RIP3, pMLKL and HMGB1 with GFAP. Bars = 50 μm.
e Double-staining of GFAP with MyD88 in uninjured human spinal cord. Notice the very weak expression of MyD88. Bar = 50 μm. f–h Representative
images of double-staining of TLR4/RIP3, TLR4/GFAP and GFAP/MyD88 in human spinal cord at 5 and 15 days post-injury. Notice the co-localization of
TLR4 with RIP3 and GFAP, and MyD88 with GFAP. Bars = 50 μm
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multiple TLRs, and TLZ stimulates both the expression of
TLR2 and TLR4 in vitro, the involvement of other TLRs
in the M1 microglia/macrophages-induced astrocytic
death is not excluded. It has been demonstrated that
necroptotic cells release factors that modulate inflamma-
tion [42], whether necroptotic astrocytes could regulate
the chronic inflammation after SCI is of interest to be fur-
ther investigated.
As the major component of glial scar, reactive astro-
cytes exhibit heterogeneous properties and exert multi-
faceted functions in SCI, such as providing nutritive and
metabolic support for neurons, inhibiting axonal growth
and modulating inflammation [43, 44]. Our data showed
that necroptotic astrocytes were less supportive for neur-
onal survival, and inhibiting astrocytic necroptosis could
rescue the neurotrophic function of reactive astrocytes,
thereby reducing cavity area and promoting the survival of
neurons surrounding lesion center which otherwise
underwent apoptosis during the secondary injury [45, 46].
It is still unknown how the properties of reactive astro-
cytes change when necroptotic signaling is activated.
Nevertheless, our data, for the first time, have revealed a
novel mechanism for the astrocytic death after SCI, imply-
ing that astrocytic necroptosis may be manipulated for
preventing secondary SCI in the future.
Conclusions
After SCI, cavity-surrounding reactive astrocytes undergo
RIP3/MLKL-mediated necroptosis, rather than apoptosis
and autophagy. The necroptosis of astrocytes is induced
by M1 microglia/macrophages, partially through TLR/
MyD88 signaling. Reactive astrocytes in injured human
spinal cord die through similar mechanism. Our data sug-
gested that inhibiting astrocytic necroptosis may be bene-
ficial for preventing secondary SCI.
Methods
Animals and human samples
RIP3−/− mice were generated as described [47]. GFAP-
CreER and ROSA-YFP mice were bought from Jackson
laboratory. Wild-type mice were bought from the animal
center of the Fourth Military Medical University. All
protocols of animal experiments were approved by the
Animal Care and Use Committee of the Fourth Military
Medical University.
Snap-frozen normal human spinal cord tissues were ob-
tained from human brain bank of school of medicine at
Zhejiang University. Biopsy of injured spinal cord tissues
were performed with informed consent obtained from
each patient prior to surgery and experiments involving
human spinal tissues were approved by the Institutional
Review Board of Tangdu Hospital, Fourth Military
Medical University.
Reagents
Necrostatin-1 was bought from Tocris. Propidium iod-
ide, DCFH-DA, GdCl3 and LPS were bought from
Sigma. ATP detecting and TUNEL staining kits were
from Promega. LPS, z-VAD and human TNFα were
from R & D system. IFN-γ and IL-4 were from Pepro-
tech. The source and dilution of antibodies were in-
cluded in Table 1.
Spinal cord contusion and in vivo treatments
C57 mice of 25–30 g were anesthetized with 1 % sodium
pentobarbital. For improving the consistency of the ex-
perimental data, W. Tazlaff developed a manual graded
forceps lateral crush SCI model [48]. Because it is difficult
for manual performance to ensure vertical orientation of
the forceps and equal degree of compression of the two
sides of the cord, we designed a mechanical version by
mounting a pair of forceps on a stereotaxic device, and
thereby its two blades could be closed simultaneously
from both sides [14]. Briefly, a 15–30 mm dorsal midline
incision was made by bilateral laminectomy. Spinal cord
injury was made at T8 vertebra (corresponding to T9 seg-
ment of the spinal cord) by lateral crushing, setting the
gap between the blades of the forceps at 0.2 mm for 15 s.
Table 1 Information for primary antibodies used
Antibodies Hosts Dilutions Sources
Anti-Arginase1 Goat IHC 1:50, WB 1:200 Santa Cruz
Anti-Beclin1 Mouse IHC 1:200, WB 1:500 Cell Signaling
Anti-β-actin Mouse WB 1:50000 Sigma
Anti-CC1 Mouse IHC1:500 Millipore
Anti-GFAP Mouse IHC1:500 Millipore
Rabbit IHC1:1000 Dako
Anti-HMGB1 Rabbit IHC 1:100, WB 1:500 Proteintech
Anti-iNOS Mouse IHC 1:200, WB 1:500 BD
Anti-Lamp2a Rabbit IHC1:200 Abcam
Anti-LC3 Mouse IHC1:500 Cell Signaling
Anti-MLKL Rat IHC 1:200, WB 1:500 Millipore
anti-pMLKL Rabbit IHC1:300 Abcam
Anti-MyD88 Rabbit IHC 1:50, WB 1:200 Abcam
Anti-NeuN Mouse IHC1:500 Millipore
Anti-OX42 Mouse IHC1:200 Abcam
Anti-RIP3 Rabbit IHC 1:200, WB 1:500 Enzo
Rabbit WB 1:500 Abcam
Anti-TLR2 Rabbit IHC1:100, WB 1:200 EPITOMICS
Anti-TLR4 Mouse IHC 1:200, WB 1:500 Abcam
Anti-YFP Goat IHC1:600 Rockland
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In vivo Propidium iodide (PI) staining
PI (10 mg/ml) was diluted in 0.9 % NaCl. Twenty mg/kg
of PI in a total volume of not more than 100 μl was ad-
ministered (i.p.) to mice 1 h before sacrifice as described
[49, 50].
Nec-1 administration
Nec-1 (7.8 mg/kg) was administrated intravenously (i.v.)
twice a day for 5 or 7 days (5 days for examining the ex-
pression of necroptotic markers, and 7 days for evaluat-
ing cavity size and locomotion recovery).
Genetic astrocyte labeling
Tamoxifen (2.5 mg) in corn oil was administered from
7 days before SCI for five successive days (Fig. 1b).
M1 microglia/macrophages depletion
One day after SCI, GdCl3 (270 μM) was injected into the
lesion area as described [25]. Three injections were made,
one in the lesion center, two at 2 mm rostral or caudal to
the epicenter, respectively. The volume of each injection is
1.5 μl. The efficiency of depletion was confirmed 3 days
after injection by western-blotting of iNOS.
M1 macrophages transplantation
Immediately after SCI, a total of 2 × 106 M1, M0 microglia
in 2 μl, or same volume of Dulbecco’s modified Eagle’s
medium (DMEM) was injected into the lesion center.
Behavior evaluation
The Basso Mouse Scale (BMS) was used to rate loco-
motor function and recovery by two investigators
blinded to the experimental design.
Cell culture and in vitro treatments
Astrocyte culture, purification and treatments
Mice at postnatal day 2–4 were freeze anesthetized, and
skin sterilized with 75 % alcohol. The brain was removed
under a stereomicroscope. The cortex was dissected and
meninges peeled off. The tissue was digested in 0.125 %
trypsin for 10 min at 37 °C and the digestion was
stopped by adding 10 % fetal bovine serum (FBS) in
DMEM. After centrifuging at 800 rpm for 5 min, the cell
suspension was moved to 75 cm flasks pre-coated with
poly-D-lysine and cultured in DMEM containing 10 %
FBS at 37 °C with 5 % CO2. Culture medium was half
changed every other day.
Astrocytes were purified as described with modifica-
tions [21, 22]. When cells reached confluence, the cul-
ture was purified by shaking at 260 rpm overnight, and
the suspended microglia and oligodendrocytes were dis-
carded. The cells were then cultured with 8 μM arabino-
side C (Ara C) for 3 days, followed by a 1 h l-leucine
methyl ester (LME, 60 μM) treatment. This cell shaking,
passaging, Ara C and LME treatment were repeated
once. Immunocytochemistry of GFAP, Sox10 and CD11b
was performed to evaluate the purity of astrocytes. Only
batches of cells with GFAP-positive cells over 99 % were
used for cell death induction.
For necroptosis induction, TNFα (100 ng/ml), LPS
(4 μg/ml) and z-VAD (20 μM) were used according to
literatures [23, 51, 52] and our preliminary experiments,
and added to the culture medium for 48 h. For collect-
ing CM from necroptotic astrocytes, TLZ was washed
off before fresh serum-free medium was added. And
then CM was collected 24 h later. For necroptosis inhib-
ition, Necrostatin-1 (20 μM) was added together with
TNFα, LPS and z-VAD (TLZ) stimulation. For interfer-
ing with TLR4/MyD88 signaling, MyD88 inhibitory pep-
tide (100 μM, Novas, Cat. NBP2-29328) was added into
medium 8 h before TLZ treatment.
Micoglia culture and treatments
When primarily cultured astrocytes reach confluency,
cells were shaken at 260 rpm for 30 min. The cells in
the suspension were collected and re-plated. The purity
of microglia was confirmed by immunostaining of
CD11b. For inducing M1 microglia, cells were treated
with LPS (100 ng/ml) plus IFN-γ (20 ng/ml) for 24 h.
For M2 polarization, cells were treated with IL-4 (20 ng/
ml) for 24 h. Then stimulators were removed and
medium refreshed for 24 h before collecting conditioned
medium. The normal cultured microglia (M0) received
no treatment except regular medium refreshment.
Spinal cord neuron culture and treatments
Spinal cords were dissected from E12-13 mice embryos.
The dorsal root ganglions and meninges were carefully
peeled off. The tissue was digested in 0.125 % trypsin for
10 min at 37 °C and the digestion was stopped by adding
10 % fetal bovine serum (FBS) in Neurobasal. After centri-
fuging at 700 rpm for 6 min, the cell suspension was
moved to 25 cm culture dishes pre-coated with poly-D-
lysine and cultured in Neurobasal containing 1 % N2 sup-
plement and 8 μM Ara C. Forty-eight hours later, Ara C
was washed off, and neurons cultured with Neurobasal
containing 1 % N2. Culture medium was half changed
every other day.
Seven days after culture, neurons were cultured with
conditioned medium from TLZ treated astrocytes or
control astrocytes for 24 h. TUNEL staining was then
performed for assessing cell death.
Bone marrow macrophage culture and treatment
Bone marrow cells were collected from the femurs and
tibias of mice by trituration using 26-gauge needles. Red
blood cells were lysed by lysis buffer containing 0.15 M
NH4Cl, 10 nM KHCO3, and 0.1 mM EDTA (pH7.4).
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After washing with RPMI 1640, the cells were cultured
in RPMI 1640 supplemented with 1 % penicillin/
streptomycin, 1 % 4-(2-hydroxyethyl) piperazine-1-
ethanesulfonic acid, 0.1 % β-mercaptoethanol, 10 %
FBS, and 20 % sL929-conditioned medium containing
macrophage colony-stimulating factor (M-CSF). After
7–10 days culture, nonadherent cells were removed.
Adherent cells were treated with LPS (100 ng/m) and
IFN-γ (20 ng/ml) for M1 polarization, or with IL-4
(20 ng/ml) for M2 polarization. Twenty-four hours
later, the stimulators were removed and medium
refreshed before collecting conditioned medium. The
normal cultured macrophages were considered as M0
macrophages.
Immunohistochemistry
Animals were sacrificed and perfused intracardially with
4 % cold paraformaldehyde phosphate buffer (pH 7.4).
Following perfusion, a 2 cm spinal cord segment with
the lesion site at its center was removed and cryopro-
tected by 25 % sucrose. For each mice, serial sections
(20 μm in thickness for each section) were cut and all
the sections were collected onto eight slides. Among
these eight slides, only 2–3 slides contain one section
which was cut through central canal. For immunostain-
ing, the sections were blocked by 0.01 M phosphate
buffered saline (PBS) containing 0.3 % Triton X-100 and
3 % bovine serum albumin (BSA) for 1 h. Primary anti-
bodies (as described in Table 1) were incubated at room
temperature overnight. After washing with PBS, sections
were incubated with their corresponding secondary anti-
bodies conjugated with Alexa Fluor 594 (donkey anti-rabbit
or anti-rat IgG, 1:800, Molecular probes), Alexa Fluor 488
(donkey anti-mouse, 1:500, Molecular probes) or Alexa
Fluor 680 (donkey anti-rabbit IgG, 1:1000, Molecular
probes) for 4 h at room temperature protected from light.
The nuclei were counterstained by Hoechst33342 (1:5000,
Sigma). All immunostained sections were photographed
under a confocal microscope (FV1000, Olympus) with
same setting. 3-D reconstruction was made using IMARIS
software.
Quantification of the immunostaining in injured spinal
cord was performed as described [14, 53, 54]. One of the
slides which contain the section cut through central
canal was randomly chose for immunostaining, and all
the sections on this slide were subjected to quantifica-
tion. The lesion area was defined by the inner lining of
GFAP stained astrocytes. After outlining the injury epi-
center, the borderline was shifted 400 μm rostrally and
caudally respectively (Fig. 1c). The resulting areas from
shifting were calculated by converting the pixels into
millimeters by using Image J. All the immunopositive
cells within the defined area were counted by using Ima-
gePro Plus Version 5.0. The slide selection and cell
counting were performed by an investigator who was
blind to experimental design.
TUNEL staining
For TUNEL/GFAP double-staining, TUNEL staining was
performed first according to the manual of DeadEND™
TUNEL system (Promega), and then followed by immu-
nostaining of GFAP.
Immuno-electron microscopy
The immune-electron microscopic study was performed
as described [55]. Briefly, at 5d after SCI, the mice were
perfusion fixed with a mixture of 4 % paraformaldehyde,
0.05 % glutaraldehyde, and 15 % saturated picric acid for
30 min. Then injured spinal cords were removed and
postfixed in the same fixative without glutaraldehyde for
3 h. Tissue sections of 50 μm were prepared with a vibra-
tome and cryoprotected by 30 % sucrose. After one freeze-
thaw treatment, the sections were blocked by 5 % bovine
serum albumin and 5 % normal goat serum, incubated with
anti-RIP3 or MLKL antibodies, and then with goat anti-
rabbit or anti-rat IgG conjugated to 1.4 nm gold particles
(1:100, Nanoprobes) at room temperature overnight se-
quentially. After rinsing, the sections were postfixed with
2 % glutaraldehyde for 45 min. Silver enhancement was
performed in the dark with an HQ Silver Kit (Nanoprobes).
The sections were further fixed with 0.5 % osmium tetrox-
ide, dehydrated with graded ethanol, replaced with propyl-
ene oxide, and flat-embedded in Epon 812. The RIP3- and
MLKL-immunoreactive areas surrounding lesion center
were selected, trimmed under a stereomicroscope and
mounted onto blank resin stubs for ultrathin sectioning.
Ultrathin sections (70–80 nm) were prepared on an LKB
Nova Ultratome (Bromma). After being counterstained
with uranyl acetate and lead citrate, the sections were ex-
amined under a JEM-1230 electron microscope (JEM,
Tokyo).
Western blot analysis
The spinal cord segments with lesion at their center
were dissected out. Each sample was homogenized in
RIPA buffer for about 20 min and incubated for another
40 min on ice, then centrifuged at 12 000 g at 4 °C.
Supernatant was boiled before sodium dodecyl sulfate
polyacrylamide gel electrophoresis. The proteins were
electrotransferred to polyvinylidene difluoride mem-
brane and reacted with primary antibodies ( as described
in Table 1) overnight at 4 °C, then with corresponding
secondary anti-mouse, anti-rabbit, or anti-rat IgG-
peroxidase (1:5000) at room temperature for 50 min.
The bands were visualized by an ECL kit (Millipore).
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In vitro PI-staining, ROS and ATP measurement
Live cell PI labeling
PI (5 μM) and Hoechst 33342 (5 μg/ml) were added into
the culture medium and incubated for 30 min at 37 °C.
Cells were then washed three times with 0.01 M PBS and
fixed with 4 % (w/v) paraformaldehyde in PB for 10 min at
room temperature and then imaged under an inverted
fluorescence microscope (IX71, Olympus) equipped with
an Olympus DP72 digital camera.
ROS measurement
Oxidation-sensitive fluorescent probe DCFH-DA was
adopted to evaluate ROS levels. Astrocytes were cultured in
96-well plates. DCFH-DA (10 μM) was added and incu-
bated for 20 min at 37 °C. After washing with PBS, the
ROS levels were determined by a multimode microplate
reader (TECAN, infinite M200), and images were photo-
graphed under an inverted fluorescence microscope (IX71,
Olympus).
ATP measurement
Intracellular levels of ATP were measured using the Cell
Titer-Glo luminescent cell viability assay kit (Promega)
according to the manufacturer’s instructions. Lumines-
cence was measured by multimode microplate reader
(TECAN, infinite M200).
Statistical analysis
For each of triplicate in vitro experiments, pictures were
taken from eight random fields. All cells in the images were
analyzed. Image Tool (University of Texas Health Sciences
Center at San Antonio) was used for quantification.
The data were presented as means ± S.E., and analyzed
by one-way ANOVA, followed by Dunnett post hoc, ex-
cept for BMS scoring which was further analyzed by Bon-
ferroni post hoc using SPSSl6.0 (Chicago, IL, USA) as
recommended [56]. P values less than 0.05 were consid-
ered as statistical significant.
Additional files
Additional file 1: Figure S1. Double-staining of GFAP with Sox10 and
CD11b after astrocyte purification. Over 99 % of cells were GFAP-positive.
Very rare could Sox10- and CD11b-positive cells be detected. Bar = 15 μm.
(TIF 2385 kb)
Additional file 2: Figure S2. Western-blotting of iNOS and Arginase 1
in M1 and M2 polarized micoglia and macrophages. (TIF 1374 kb)
Additional file 3: Figure S3. Western-blotting and quantification of
RIP3, MLKL and HMGB1 in astrocytes treated by conditioned medium from
M0 microglia (M0 CM), M1 microglia (M1 CM), and M2 microglia (M2 CM).
Notice that M1 CM has the strongest effects in stimulating the expression of
RIP3, MLKL and HMGB1. *P <0.05, **P <0.01. n = 3. (TIF 3027 kb)
Additional file 4: Figure S4. Western-blotting of iNOS at 5 dpi in GdCl3
or PBS treated mice. The expression of iNOS was reduced in GdCl3
treated mice. *P <0.05. n = 3. (TIF 87 kb)
Additional file 5: Figure S5. Western-blotting of TLR2 in purified
astrocytes after TLZ treatment. (TIF 325 kb)
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